Esomeprazole Strontium
Product Images NDC 65162-957

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Strontium (NDC 65162-957). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Esomeprazole Strontium Delayed Release Capsules 1)

Chemical structure of esomeprazole strontium with two esomeprazole molecules complexed to strontium ion and four water molecules, illustrating the molecular arrangement.*

FDA Label Image

Figure2 (Esomeprazole Strontium Delayed Release Capsules 2)

Line graph depicting percent of a measure maintained over six months for different doses of Esomeprazole Magnesium (44.6 mg, 22.3 mg, and 11.15 mg) compared with placebo. The vertical axis shows percent maintained and the horizontal axis shows time in months, with data points for each group linking values over time.*

FDA Label Image

Figure3 (Esomeprazole Strontium Delayed Release Capsules 3)

A line graph depicting the percent maintained over a six-month period for different dosages of Esomeprazole Magnesium (44.6 mg, 22.3 mg, and 11.15 mg) compared to placebo. The y-axis represents percent maintained, and the x-axis represents time in months, showing the varying efficacy trends among the groups.*

FDA Label Image

Figure4 (Esomeprazole Strontium Delayed Release Capsules 4)

A line graph depicting the percent of patients symptom-free over 28 diary days for three groups: Esomeprazole Magnesium 44.6 mg, Esomeprazole Magnesium 22.3 mg, and placebo. The graph shows symptom-free percentages increasing over time, with both Esomeprazole groups outperforming placebo throughout the period.*

FDA Label Image

Figure5 (Esomeprazole Strontium Delayed Release Capsules 5)

A line graph titled "Percent of Patients Symptom-Free of Heartburn by Day" showing three lines representing Esomeprazole Magnesium 44.6 mg, Esomeprazole Magnesium 22.3 mg, and Placebo. The x-axis is labeled "Diary Day" from 0 to 28, and the y-axis is labeled "Percent of Patients Symptom-Free" from 0 to 100%.*

FDA Label Image

24.65 mg 30 Ct Bottle Label (Esomeprazole Strontium Delayed Release Capsules 6)

Label for Esomeprazole strontium delayed-release capsules 24.65 mg, supplied in a package of 30 capsules by Amneal Pharmaceuticals LLC. The label includes dosage information, storage instructions, and licensing from Hanmi Pharm. Co. Ltd., Seoul, Korea. The label also features the Amneal Pharmaceuticals logo and barcode.*

FDA Label Image

49.3 mg 30 Ct Bottle Label (Esomeprazole Strontium Delayed Release Capsules 7)

Label for Esomeprazole strontium delayed-release capsules, 49.3 mg strength, supplied by Amneal Pharmaceuticals LLC. The label states 30 capsules per container, with storage instructions between 20° to 25°C and dosage guidance referencing the package insert. The product is Rx only, licensed from Hanmi Pharm. Co., Ltd., Seoul, Korea, and distributed from Glasgow, KY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.